Tawfik Gharbaoui

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Arena Pharmaceuticals, Inc., Mirati Therapeutics, Inc., Merck + Co., Inc.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tawfik Gharbaoui. Retrieved from https://idiyas.com/inventor/tawfik-gharbaoui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 5)

% Patents Active = 73.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 5.2

ph-index = 8

Forward Citations = 125(Granted Patents)

Location History:

Esconido, CA (US) (2017)
Escondido, CA (US) (2008 - 2023)

Company Filing History:

17 out of 218

Arena Pharmaceuticals, Inc.

patents

2 out of 44

Mirati Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286431 - Crystalline forms of a KRas G12C inhibitor (2025-04-29),

2. 12281113 - Crystalline forms of a KRas G12C inhibitor (2025-04-21),

3. 11674163 - Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof (2023-06-13),

4. 11149292 - Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof (2021-10-19),

5. 10787437 - Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor (2020-09-29),

6. 10059691 - Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor (2018-08-28),

7. 9783502 - [object Object] (2017-10-10),

8. 9556149 - Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor (2017-01-31),

9. 9447041 - Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof (2016-09-20),

10. 9199940 - [object Object] (2015-12-01),

11. 9175320 - Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof (2015-11-03),

12. 9085581 - Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof (2015-07-21),

13. 8853419 - [object Object] (2014-10-07),

14. 8822727 - [object Object] (2014-09-02),

15. 8637555 - Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof (2014-01-28),

Title: Inventor Tawfik Gharbaoui: Pioneering Innovations in Escondido

Introduction: Tawfik Gharbaoui is a distinguished inventor based in Escondido, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Gharbaoui's recent patents include advancements in renewable energy systems, smart home technologies, and medical devices, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: With a career spanning over two decades, Gharbaoui has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, Gharbaoui has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Tawfik Gharbaoui's relentless pursuit of innovation and his passion for creating technologies that make a difference have solidified his reputation as a trailblazing inventor in Escondido and beyond.

Profile summary based on public USPTO records.